Where innovation happens, matters

News & Events

The EFPIA view

Where innovation happens, matters

01.09.22

Innovation isn’t an abstract concept. It transforms the lives of patients. It means new experiences, moments shared, and memories made. We want Europe to be at the forefront of that innovation. #WeWontRest until patients everywhere can see the results, in black and white.

As Europe re-evaluates its pharmaceutical policy framework the challenge for the next decade(s) is not if medical innovation will happen, but where it will happen. The EU has been eclipsed by the US as a world leader in medical innovation and faces increasingly intense competition for life science investment from China, other parts of Asia, Switzerland and the UK.

Where innovation happens mattersEurope needs a vibrant research ecosystem that will not only improve patient care, drive economic performance and resilience, but also further benefit the efficiency of health care systems.

Read more

It matters to patientsWe have never had as many medicines in development as we do today. But how can this potential be realized for patients, how can Europe step up to the challenge?
Read more

It matters to health systemsR&D to discover, develop and deliver transformative medicines that address important treatment gaps in severe illnesses, at a speed that rapidly and appropriately meets our communities’ health needs, is essential to improving health care systems and outcomes.
Read more

It matters to our research ecosystemThe pharmaceutical industry is ready to respond to patients’ rising needs and emerging global health challenges – it needs a conducive legislative and policy framework, and robust research ecosystem that supports innovation.
Read more

It matters to our resilience and economic growthToday’s pharmaceutical sector in EU seems healthy, with €118 billion external EU trade surplus and over 830,000 people directly employed, but consistently lags in innovation behind U.S., warns major investor.
Read more

The revision of the Pharmaceutical Legislation will define the future of innovation in Europe. Let’s ensure Europeans can see the results of innovation in black and white.